[Responses to targeted therapies: colorectal cancer]

MeSH terms

• Adenocarcinoma / drug therapy*
• Adenocarcinoma / genetics
• Adenocarcinoma / metabolism
• Adenocarcinoma / pathology
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal / therapeutic use
• Antineoplastic Agents / pharmacology
• Antineoplastic Agents / therapeutic use*
• Colonic Neoplasms / drug therapy*
• Colonic Neoplasms / genetics
• Colonic Neoplasms / metabolism
• Colonic Neoplasms / pathology
• Drug Delivery Systems / methods*
• ErbB Receptors / antagonists & inhibitors*
• ErbB Receptors / biosynthesis
• ErbB Receptors / genetics
• ErbB Receptors / immunology
• Gene Dosage
• Humans
• Neoplasm Proteins / antagonists & inhibitors*
• Neoplasm Proteins / biosynthesis
• Neoplasm Proteins / genetics
• Neoplasm Proteins / immunology
• Prognosis
• Proto-Oncogene Proteins / antagonists & inhibitors*
• Proto-Oncogene Proteins / biosynthesis
• Proto-Oncogene Proteins / genetics
• Proto-Oncogene Proteins / immunology
• Proto-Oncogene Proteins p21(ras)
• Treatment Outcome
• ras Proteins / antagonists & inhibitors*
• ras Proteins / biosynthesis
• ras Proteins / genetics
• ras Proteins / immunology